Related references
Note: Only part of the references are listed.Rac1 GTPase-deficient HeLa cells present reduced DNA repair, proliferation, and survival under UV or gamma irradiation
Gisele Espinha et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2015)
Radiation resistance: Cancer stem cells (CSCs) and their enigmatic pro-survival signaling
Ira Skvortsova et al.
SEMINARS IN CANCER BIOLOGY (2015)
The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics
Aaron N. Hata et al.
CANCER DISCOVERY (2015)
Rac1 as a potential therapeutic target for chemo-radioresistant head and neck squamous cell carcinomas (HNSCC)
S. Skvortsov et al.
BRITISH JOURNAL OF CANCER (2014)
Targeting the NFκB Signaling Pathways for Breast Cancer Prevention and Therapy
Wei Wang et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Oncogenes in melanoma: An update
Manfred Kunz
EUROPEAN JOURNAL OF CELL BIOLOGY (2014)
Transcription Factors NRF2 and NF-κB Are Coordinated Effectors of the Rho Family, GTP-binding Protein RAC1 during Inflammation
Antonio Cuadrado et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Identification of novel determinants of resistance to lapatinib in ERBB2-amplified cancers
D. Wetterskog et al.
ONCOGENE (2014)
Positive Feedback Regulation of Proliferation in Vascular Smooth Muscle Cells Stimulated by Lipopolysaccharide Is Mediated through the TLR 4/Rac1/Akt Pathway
Dehua Jiang et al.
PLOS ONE (2014)
The influence of AKT isoforms on radiation sensitivity and DNA repair in colon cancer cell lines
Sara Haggblad Sahlberg et al.
TUMOR BIOLOGY (2014)
Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation
Ying Yan et al.
ONCOTARGET (2014)
Synergistic interactions between camptothecin and EGFR or RAC1 inhibitors and between imatinib and Notch signaling or RAC1 inhibitors in glioblastoma cell lines
Linda Sooman et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
ROS Production and NF-κB Activation Triggered by RAC1 Facilitate WNT-Driven Intestinal Stem Cell Proliferation and Colorectal Cancer Initiation
Kevin B. Myant et al.
CELL STEM CELL (2013)
RAC1: An Emerging Therapeutic Option for Targeting Cancer Angiogenesis and Metastasis
Hemant K. Bid et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option
Ziyan Yuan Pessetto et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
New insights into the roles of ATM and DNA-PKcs in the cellular response to oxidative stress
Benjamin P. C. Chen et al.
CANCER LETTERS (2012)
Rac signaling in breast cancer: A tale of GEFs and GAPs
Eva Wertheimer et al.
CELLULAR SIGNALLING (2012)
Regulation of cell death and autophagy by IKK and NF-κB: critical mechanisms in immune function and cancer
Albert S. Baldwin
IMMUNOLOGICAL REVIEWS (2012)
Rho GTPase signaling in the development of colorectal cancer
Fernanda Leve et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Akt Promotes Post-Irradiation Survival of Human Tumor Cells through Initiation, Progression, and Termination of DNA-PKcs-Dependent DNA Double-Strand Break Repair
Mahmoud Toulany et al.
MOLECULAR CANCER RESEARCH (2012)
RAC1 GTPase plays an important role in γ-irradiation induced G2/M checkpoint activation
Ying Yan et al.
BREAST CANCER RESEARCH (2012)
Inactivation of Rac1 reduces Trastuzumab resistance in PTEN deficient and insulin-like growth factor I receptor overexpressing human breast cancer SKBR3 cells
Yong Zhao et al.
CANCER LETTERS (2011)
Optimized digital counting colonies of clonogenic assays using ImageJ software and customized macros: Comparison with manual counting
Zhongli Cai et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2011)
TARGETING THE AKT/GSK3β/CYCLIN D1/CDK4 SURVIVAL SIGNALING PATHWAY FOR ERADICATION OF TUMOR RADIORESISTANCE ACQUIRED BY FRACTIONATED RADIOTHERAPY
Tsutomu Shimura et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Rac1 is crucial for Ras-dependent skin tumor formation by controlling Pak1-Mek-Erk hyperactivation and hyperproliferation in vivo
Z. Wang et al.
ONCOGENE (2010)
Telomerase-immortalized human mammary stem/progenitor cells with ability to self-renew and differentiate
Xiangshan Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
G. Kroemer et al.
CELL DEATH AND DIFFERENTIATION (2009)
Rac1 GTPase: A Rac of All Trades
E. E. Bosco et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Rac1 contributes to trastuzumab resistance of breast cancer cells: Rac1 as a potential therapeutic target for the treatment of trastuzumab-resistant breast cancer
Milos Dokmanovic et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer
Johan Bussink et al.
LANCET ONCOLOGY (2008)
Mammalian Rho GTPases:: new insights into their functions from in vivo studies
Sarah J. Heasman et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Irradiation-induced G2/M checkpoint response requires ERK1/2 activation
Y. Yan et al.
ONCOGENE (2007)
Radiation-induced cell signaling: inside-out and outside-in
Kristoffer Valerie et al.
MOLECULAR CANCER THERAPEUTICS (2007)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve et al.
CANCER CELL (2006)
Bcl-XL is qualitatively different from and ten times more effective than Bcl-2 when expressed in a breast cancer cell line
Aline A. Fiebig et al.
BMC CANCER (2006)
The Rac and Rho hall of fame - A decade of hypertrophic signaling hits
JH Brown et al.
CIRCULATION RESEARCH (2006)
Rac1 modulates sphingosine 1-phosphate-mediated activation of phosphoinositide 3-kinase/Akt signaling pathways in vascular endothelial cells
E Gonzalez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
NF-κB modulation and ionizing radiation:: mechanisms and future directions for cancer treatment
N Magné et al.
CANCER LETTERS (2006)
BRCA1-mediated G2/M cell cycle arrest requires ERK1/2 kinase activation
Y Yan et al.
ONCOGENE (2005)
Immunophenotypic analysis of inflammatory breast cancers: identification of an 'inflammatory signature'
E Charafe-Jaufrret et al.
JOURNAL OF PATHOLOGY (2004)
Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints
A Sancar et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2004)
Rational design and characterization of a Rac GTPase-specific small molecule inhibitor
Y Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
PAKI phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation
JK Slack-Davis et al.
JOURNAL OF CELL BIOLOGY (2003)
被撤回的出版物: BRCA1-induced apoptosis involves inactivation of ERK1/2 activities (Retracted article. See vol. 294, pg. 8309, 2019)
Y Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Rac-PAK signaling stimulates extracellular signal- regulated kinase (ERK) activation by regulating formation of MEKI-ERK complexes
ST Eblen et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53
DM Tang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Rac1 and RhoG promote cell survival by the activation of PI3K and Akt, independently of their ability to stimulate JNK and NF-κB
C Murga et al.
ONCOGENE (2002)
Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b
A Schnelzer et al.
ONCOGENE (2000)
Share Paper
